Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 611,071Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 42Eli Lilly

02 1ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

02

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

03

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

04

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

10

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

11

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

12

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

13

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

14

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

15

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

16

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

17

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

18

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

19

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

20

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank